NUGL Ár/értékesítés
Mi az NUGL Ár/értékesítés?
A Ár/értékesítés az NUGL, Inc. - 55.99
Mi a Ár/értékesítés meghatározása?
Az ár / árbevétel arány a vállalat részvényeinek árbevételéhez képest.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Ár/értékesítés a Technology szektor a OTC-on cégekben a NUGL -hoz képest
Mit csinál NUGL?
NUGL Inc. operates as a vertically integrated medical cannabis company. It operates cultivation facility, processing facility, three retail dispensaries, conditional licenses, and supplies and exports medical cannabis primarily in the Caribbean, Australia, and South America. The company was founded in 2018 and is based in Kingston, Jamaica.
ár/értékesítés -hoz hasonló cégek NUGL
- Sunwah Kingsway Capital nak Ár/értékesítés 55.53 van
- Strata-X nak Ár/értékesítés 55.54 van
- Vermillion nak Ár/értékesítés 55.62 van
- abrdn Australia Equity Fund Inc nak Ár/értékesítés 55.62 van
- Boulder Growth & Income Fund Inc nak Ár/értékesítés 55.79 van
- iShares Trust - iShares China Large-Cap ETF nak Ár/értékesítés 55.81 van
- NUGL nak Ár/értékesítés 55.99 van
- iShares Trust - iShares 20+ Year Treasury Bond ETF nak Ár/értékesítés 56.04 van
- True Leaf Brands nak Ár/értékesítés 56.06 van
- Ascletis Pharma nak Ár/értékesítés 56.16 van
- Aberdeen New Thai Investment Trust PLC nak Ár/értékesítés 56.35 van
- iShares, - iShares MSCI South Korea ETF nak Ár/értékesítés 56.42 van
- Spruce Ridge Resources nak Ár/értékesítés 56.57 van